KLF4 and osteosarcoma: Thus, KLF4 expression was associated to the development of drug-induced stemness phenotypes in osteosarcoma cells via a mechanism that seems to be mediated by the activation p38 MAPK signaling [76] and can be inhibited by statins [61].